Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Autonomic dysfunction and risk of severe hypoglycemia among individuals with type 2 diabetes
Arnaud D. Kaze, … , Michael R. Rickels, Justin B. Echouffo-Tcheugui
Arnaud D. Kaze, … , Michael R. Rickels, Justin B. Echouffo-Tcheugui
Published November 1, 2022
Citation Information: JCI Insight. 2022;7(22):e156334. https://doi.org/10.1172/jci.insight.156334.
View: Text | PDF
Research Article Cardiology Endocrinology

Autonomic dysfunction and risk of severe hypoglycemia among individuals with type 2 diabetes

  • Text
  • PDF
Abstract

There are limited data on the link between cardiac autonomic neuropathy (CAN) and severe hypoglycemia in type 2 diabetes. Here, we evaluated the associations of CAN with severe hypoglycemia among 7,421 adults with type 2 diabetes from the Action to Control Cardiovascular Risk in Diabetes study. CAN was defined using ECG-derived measures. Cox’s and Andersen-Gill regression models were used to generate HRs (HRs) for the first and recurrent severe hypoglycemic episodes, respectively. Over 4.7 years, there were 558 first and 811 recurrent hypoglycemic events. Participants with CAN had increased risks of a first episode or recurrent episodes of severe hypoglycemia. The intensity of glycemic management modified the CAN association with hypoglycemia. In the standard glycemic management group, compared with those of participants without CAN, HRs for a first severe hypoglycemia event and recurrent hypoglycemia were 1.58 and 1.96, respectively. In the intensive glycemic management group, HRs for a first severe hypoglycemia event and recurrent hypoglycemia were 1.10 and 1.24, respectively. In summary, CAN was independently associated with higher risks of a first hypoglycemia event and recurrent hypoglycemia among adults with type 2 diabetes, with the highest risk observed among those on standard glycemic management.

Authors

Arnaud D. Kaze, Matthew F. Yuyun, Rexford S. Ahima, Michael R. Rickels, Justin B. Echouffo-Tcheugui

×

Figure 1

Cumulative incidence of hypoglycemic events.

Options: View larger image (or click on image) Download as PowerPoint
Cumulative incidence of hypoglycemic events.
Cumulative incidence of fir...
Cumulative incidence of first (A) and recurrent (B) severe hypoglycemic events by glycemia treatment arm and CAN. Severe hypoglycemia was defined as symptomatic, severe hypoglycemia requiring medical assistance. CAN, cardiac autonomic neuropathy.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts